Evolva to acquire Fluxome assets

Evolva to acquire Fluxome assets

Evola plans to buy parts of the Danish company undergoing reconstruction.

Evolva Holding SA (SIX: EVE) announces it has entered an agreement to acquire certain assets owned by Fluxome Sciences A/S, a Danish private company that is in reconstruction. The agreement is subject to creditor and court approval, which is anticipated to occur in the next two weeks. Further information will be provided if approval is obtained. The transaction is not expected to change Evolva’s 2012 financial projections.

About Evolva
Evolva’s mission is to discover and provide innovative, sustainable ingredients for health, nutrition and wellness. Evolva uses biosynthetic and evolutionary technologies to create and optimize small molecule compounds and their production routes. For more information see evolva.com.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.